Medical Innovation Exchange

JPM23: Sage CEO says postpartum depression is no niche, as zuranolone aims to fill gaps in mental healthcare

https://www.fiercebiotech.com/biotech/jpm23-sage-ceo-says-post-partum-depression-no-niche-zuranolone-aims-fill-gaps-depression

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!